Name | osteocalcin |
---|---|
Synonyms | BGLAP; BGP; Bone Gla protein; Bone gamma carboxyglutamaic acid protein; Gamma carboxyglutamicacid protein; Gamma carboxyglutamic acid containing protein; Osteocalcin; Osteocalcin precursor… |
Name | DMPA |
---|---|
CAS |
PubMed | Abstract | RScore(About this table) | |
---|---|---|---|
8521712 | Naessen T, Olsson SE, Gudmundson J: Differential effects on bone density of progestogen-only methods for contraception in premenopausal women. Contraception. 1995 Jul;52(1):35-9. The changes in bone density were consistent with the changes in biochemical indices for bone metabolism; DMPA users showed signs of increased bone turnover and users of levonorgestrel showed increased bone formation with increased levels of both alkaline phosphatase (p = 0.004) and osteocalcin (p = 0.007). |
31(0,1,1,1) | Details |
11231998 | Ott SM, Scholes D, LaCroix AZ, Ichikawa LE, Yoshida CK, Barlow WE: Effects of contraceptive use on bone biochemical markers in young women. J Clin Endocrinol Metab. 2001 Jan;86(1):179-85. Women aged 18-39 yr who were using depot medroxyprogesterone acetate (DMPA) contraception were recruited for the study; comparison women were matched by age and clinic location. Biochemical measurements were serum calcium, PTH and osteocalcin, and urine N-telopeptide. |
1(0,0,0,1) | Details |
17185205 | Harel Z, Gold M, Cromer B, Bruner A, Stager M, Bachrach L, Wolter K, Reid C, Hertweck P, Nelson A, Nelson D, Coupey S, Johnson C, Burkman R, Bone H: Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers. J Adolesc Health. 2007 Jan;40(1):44-53. Epub 2006 Oct 27. METHODS: The population was comprised of 389 healthy postmenarchal adolescent girls aged 11-18 years, who were recruited into a prospective study of the effect of depot medroxyprogesterone acetate (DMPA) on bone health in adolescents. Before study initiation, BMD at the lumbar spine, total hip, and femoral neck was measured by dual-energy X-ray absorptiometry (DXA), and markers of bone metabolism (serum bone-specific alkaline phosphatase [BAP], serum osteocalcin, and urinary N-telopeptide [uNTX]) were measured. |
1(0,0,0,1) | Details |
16982229 | Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA: Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling. Contraception. 2006 Oct;74(4):297-302. Epub 2006 Jun 16. PURPOSE AND METHOD: Our objective is to evaluate the effects of the long-term use of depot medroxyprogesterone acetate (DMPA) as a method of contraception on bone mineral density (BMD) and bone remodeling. Serum osteocalcin (OC), a bone formation marker, was measured by enzyme amplification sorbent immunoassay. |
1(0,0,0,1) | Details |